发明名称 SUBLINGUAL USE OF INHIBITORS IN THE BIOSYNTHESIS OF CHOLESTEROL
摘要 The present invention is a method introducing the sublingual placement of statin drugs whose names include : Fluvastatin, Atorvastatin, Lovastatin, Pravastatin and Simvastatin for heart related and other vascular emergencies. Current research challenges are developing many new derivatives and new classes of these HMG-CoA reductase inhibitors, which alter the biosynthesis of cholesterol. This method applies these medications (statin drugs) in a form such as sublingual (under the tongue) for rapid absorption and immediate high blood levels similar to that of nitroglycerin. The advantage of this method is that it will benefit those who are stricken with strokes and heart attacks by therefore saving lives and costs of medical care.
申请公布号 WO03007846(A1) 申请公布日期 2003.01.30
申请号 WO2002US21287 申请日期 2002.07.19
申请人 WEISS, SOL 发明人 WEISS, SOL
分类号 A61K9/00;(IPC1-7):A61F2/02;A61F13/02;A61K9/20;A61K9/48 主分类号 A61K9/00
代理机构 代理人
主权项
地址